NDC 41250-943

Meijer Antibiotic Plus Pain Relief

Neomycin Sulfate, Polymyxin B Sulfate, And Pramoxine Hci

Meijer Antibiotic Plus Pain Relief is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Meijer, Inc.. The primary component is Neomycin Sulfate; Polymyxin B Sulfate; Pramoxine Hydrochloride.

Product ID41250-943_602d0c43-53bd-d221-e053-2a91aa0a81a9
NDC41250-943
Product TypeHuman Otc Drug
Proprietary NameMeijer Antibiotic Plus Pain Relief
Generic NameNeomycin Sulfate, Polymyxin B Sulfate, And Pramoxine Hci
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2015-01-19
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart347
Labeler NameMeijer, Inc.
Substance NameNEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
Active Ingredient Strength4 mg/g; [USP'U]/g; mg/g
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 41250-943-14

1 TUBE in 1 CARTON (41250-943-14) > 14 g in 1 TUBE
Marketing Start Date2015-01-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 41250-943-14 [41250094314]

Meijer Antibiotic Plus Pain Relief CREAM
Marketing CategoryOTC monograph not final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-01-19
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
NEOMYCIN SULFATE3.5 mg/g

OpenFDA Data

SPL SET ID:ef35471c-ba7f-4a29-abaf-fd1cff542a85
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1359360
  • UPC Code
  • 0708820940314
  • NDC Crossover Matching brand name "Meijer Antibiotic Plus Pain Relief" or generic name "Neomycin Sulfate, Polymyxin B Sulfate, And Pramoxine Hci"

    NDCBrand NameGeneric Name
    41250-943Meijer Antibiotic Plus Pain ReliefNeomycin Sulfate, Polymyxin B Sulfate, and Pramoxine HCI
    41250-505meijer Antibiotic Plus Pain Reliefmeijer Antibiotic Plus Pain Relief
    55319-033FAMILY WELLNESS TRIPLE ANTIBIOTIC PLUS PAIN RELIEFNeomycin Sulfate, Polymyxin B Sulfate, and Pramoxine HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.